Concert Pharmaceuticals, Inc. Pre-Tax Profit Margin 2014-2022 | CNCE
Concert Pharmaceuticals, Inc. pre-tax profit margin from 2014 to 2022. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Pre-Tax Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
2022-09-30 |
$0.00B |
$-0.13B |
inf% |
2022-06-30 |
$0.00B |
$-0.13B |
-12500.00% |
2021-12-31 |
$0.03B |
$-0.08B |
-245.45% |
2021-09-30 |
$0.03B |
$-0.07B |
-203.03% |
2021-06-30 |
$0.03B |
$-0.06B |
-173.53% |
2021-03-31 |
$0.01B |
$-0.08B |
-962.50% |
2020-12-31 |
$0.01B |
$-0.07B |
-925.00% |
2020-09-30 |
$0.01B |
$-0.07B |
-900.00% |
2020-06-30 |
$0.01B |
$-0.07B |
-1166.67% |
2020-03-31 |
$0.00B |
$-0.08B |
inf% |
2019-12-31 |
$0.00B |
$-0.08B |
-7800.00% |
2019-09-30 |
$0.00B |
$-0.08B |
-7900.00% |
2019-06-30 |
$0.00B |
$-0.08B |
-7900.00% |
2019-03-31 |
$0.00B |
$-0.07B |
-7300.00% |
2018-12-31 |
$0.01B |
$-0.06B |
-550.00% |
2018-09-30 |
$0.01B |
$-0.04B |
-430.00% |
2018-06-30 |
$0.15B |
$0.10B |
67.53% |
2018-03-31 |
$0.15B |
$0.10B |
67.53% |
2017-12-31 |
$0.14B |
$0.10B |
65.97% |
2017-09-30 |
$0.14B |
$0.09B |
63.89% |
2017-06-30 |
$0.00B |
$-0.05B |
inf% |
2017-03-31 |
$0.00B |
$-0.05B |
inf% |
2016-12-31 |
$0.00B |
$-0.05B |
inf% |
2016-09-30 |
$0.01B |
$-0.04B |
-370.00% |
2016-06-30 |
$0.01B |
$-0.04B |
-291.67% |
2016-03-31 |
$0.07B |
$0.02B |
30.77% |
2015-12-31 |
$0.07B |
$0.03B |
37.88% |
2015-09-30 |
$0.06B |
$0.02B |
26.32% |
2015-06-30 |
$0.06B |
$0.02B |
27.12% |
2015-03-31 |
$0.01B |
$-0.03B |
-485.71% |
2014-12-31 |
$0.01B |
$-0.03B |
-400.00% |
2014-09-30 |
$0.01B |
$-0.03B |
-362.50% |
2014-06-30 |
$0.01B |
$-0.03B |
-560.00% |
2014-03-31 |
$0.02B |
$-0.01B |
-52.38% |
2013-12-31 |
$0.03B |
$-0.01B |
-24.00% |